We always recommend consulting with your healthcare professional to ensure you are making the best decision for your body and needs as this is a deeply personal issue. However, Equelle has been clinically studied and shown to be safe.
Your body has two main types of estrogen receptors, alpha receptors and beta receptors. Alpha receptors are primarily in your breast, ovarian, and uterine tissues. Beta receptors are primarily in places like the lining of your blood vessels and some parts of your brain. Estrogen, and estrogen hormone replacement therapies, bind to both alpha and beta receptors. S-equol has a similar molecular structure to estrogen but mostly binds to beta receptors.
By favoring these beta receptors, S-equol:
Mimics the benefits of estrogen and relieves menopause symptoms
Does not increase your risk for breast cancer and is not associated with changes in sex or thyroid hormones or endometrial health
S-equol is derived from soy using a patented process. A report for the American Institute for Cancer Research notes that a moderate amount of soy (1 to 2 servings a day) is considered safe for survivors and may even be beneficial. Only trace amounts of soy compounds remain in the final Equelle product.